Gene expression in the brain during reovirus encephalitis

Kenneth L Tyler1, J Smith Leser, Tzu L Phang

  • 1Department of Neurology, University of Colorado-Denver, Anschutz Medical Campus, Aurora, Colorado, USA.

Journal of Neurovirology
|February 18, 2010
PubMed

Insights

Reovirus encephalitis activates innate immunity early and later induces cytokine signaling and apoptosis, contributing to central nervous system (CNS) injury. Targeting these distinct pathways may offer novel therapeutic strategies for viral brain diseases.

Area of Science:

  • Neurovirology
  • Immunology
  • Molecular Biology

Background:

  • Viral encephalitis poses a global health challenge, causing significant morbidity and mortality.
  • Understanding virus-induced gene regulation in the central nervous system (CNS) is crucial for developing effective treatments.

Purpose of the Study:

  • To identify differentially regulated genes and pathways during reovirus encephalitis using microarray analysis.
  • To explore potential therapeutic targets for virus-induced CNS diseases by comparing early and late gene expression profiles.

Main Methods:

  • Microarray analysis was performed on brains of reovirus-infected and mock-infected mice at early and late time points post-infection.
  • Gene expression profiles were analyzed to identify up-regulated cellular genes and associated biological pathways.

Main Results:

  • Early infection showed up-regulation of 130 genes, primarily linked to innate immune responses and interferon signaling.
  • Late infection revealed significant up-regulation of 1374 genes, correlating with CNS injury and disease pathology.
  • Late-stage gene expression also highlighted pathways involved in cytokine signaling and apoptosis, contributing to CNS damage.

Conclusions:

  • The study reveals a temporal shift in virus-induced gene expression from early innate immune responses to later cytokine signaling and apoptosis.
  • This dynamic gene expression pattern suggests a potential therapeutic window.
  • Targeting late-stage pathogenic pathways while preserving early protective responses could be a novel strategy for managing viral encephalitis.

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...